· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
QUANTITATIVE BIOSCIENCES, INC. — QUANTITATIVE BIOSCIENCES 401(K) PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250412220354NAL0048729202039
QUANTITATIVE BIOSCIENCES, INC.
Form 5500-SF
FILING_RECEIVED
QUANTITATIVE BIOSCIENCES 401(K) PLAN
401(k) retirement plan
Active participants
11
Accounts w/ balance
15
Plan assets (EOY)
$1.2M
Net assets (EOY)
$1.2M
Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
QUANTITATIVE BIOSCIENCES, INC.
.
Find decision makers
Plan sponsor
Name
QUANTITATIVE BIOSCIENCES, INC.
EIN
27-2716733
Address
6185 CORNERSTONE CT EAST · SUITE 107 · SAN DIEGO, CA · 92121
Phone
(858) 208-0280
Industry
Professional & Technical Services
see all
Plan administrator
Name
GUIDELINE RK, LLC
EIN
30-1418950
City
BURLINGAME, CA
Phone
(888) 228-3491
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-04-12
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2S · Automatic enrollment
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Professional & Technical Services plans
CURI BIO, INC.
CURI BIO 401(K) PLAN
$1.2M · 38 participants
CENTERA BIOSCIENCE INC.
CENTERA BIOSCIENCE 401(K) PLAN
$1.2M · 75 participants
AVENZO THERAPEUTICS INC
AVENZO THERAPEUTICS INC 401(K) PLAN
$1.2M · 34 participants
MYROBALAN THERAPEUTICS, INC
MYROBALAN THERAPEUTICS 401(K) PLAN
$1.2M · 21 participants
TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS, LLC
TRANSFORMATIVE PHARMACEUTICAL SOLUTIONS, LLC 401(K) PLAN
$1.2M · 87 participants
100
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Audit & trust (Schedule H)
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
PRILENIA THERAPEUTICS INC
PRILENIA THERAPEUTICS, INC. 401K AND PROFIT SHARING PLAN
$1.2M · 18 participants
Large plans in California
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND
$215.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND E
$190.9B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND F
$188.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
RUSSELL 1000 INDEX FUND
$187.7B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
CASH EQUIVALENT FUND II
$125.0B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
BLACKROCK MSCI ACWI EX-US IMI INDEX FUND E
$88.3B
